Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Cancer Res. 2013 Oct 31;73(24):7189–7198. doi: 10.1158/0008-5472.CAN-12-4174

Figure 6. Anti-OX40 infusion increases tumor-specific immune response.

Figure 6

(A-B) PBMC from two patients with melanoma, before and after anti-OX40, were co-cultured with either autologous, HLA-mis-matched melanoma cell lines or flu. IFN-γ in the supernatant was measured by ELISA. Anti-tumor-specific antibodies were measured by Western blot (C) serum from a patient with melanoma was used to probe lysates (15μg of protein/lane) from a melanoma cell line (FEMX) or a human embryonic kidney cell line (HEK 293) at different times after anti-OX40.